Envestnet Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $961K | Sell |
189,901
-15,992
| -8% | -$80.9K | ﹤0.01% | 3301 |
|
|
2025
Q1 | $1.09M | Sell |
205,893
-25,863
| -11% | -$137K | ﹤0.01% | 3145 |
|
|
2024
Q4 | $1.57M | Buy |
231,756
+11,646
| +5% | +$78.7K | ﹤0.01% | 2845 |
|
|
2024
Q3 | $1.45M | Buy |
220,110
+75,974
| +53% | +$501K | ﹤0.01% | 2882 |
|
|
2024
Q2 | $1.08M | Buy |
144,136
+10,216
| +8% | +$76.6K | ﹤0.01% | 2987 |
|
|
2024
Q1 | $1.34M | Buy |
133,920
+6,480
| +5% | +$64.6K | ﹤0.01% | 2827 |
|
|
2023
Q4 | $1.26M | Buy |
+127,440
| New | +$1.26M | ﹤0.01% | 2766 |
|